Inogen

Inogen FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Inogen (INGN) as of Oct 6, 2026 is 94.95 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 31.15 % — a change of 204.83% (higher).

FCF Conversion

94.95 %

YoY

204.83%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Inogen is 2026 94.95 % . FCF Conversion Rate (FCF/EBITDA) of Inogen was 2025 31.15 % . It decreases by 204.83% higher compared to the previous year.

The Inogen FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
90.66 USD
Jan 1, 2019
162.67 USD
Jan 1, 2020
-337.47 USD
Jan 1, 2021
4.77 USD
Jan 1, 2022
70.14 USD
Jan 1, 2023
29.04 USD
Jan 1, 2024
31.15 USD
Jan 1, 2025
94.95 USD
The Inogen FCF Conversion history
YEARFCF ConversionYoY
94.95 %+204.83%
31.15 %+7.27%
29.04 %-58.59%
70.14 %+1,370.76%
4.77 %-101.41%
-337.47 %-307.46%
162.67 %+79.42%
90.66 %-62.12%
239.34 %+113.36%
112.18 %-49.38%
221.60 %-2,901.15%
-7.91 %—
Access this data via the Eulerpool API

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

FCF Conversion Rate (FCF/EBITDA) of Inogen is 94.95 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Inogen changed from 31.15 % to 94.95 %, representing a 204.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Inogen since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Inogen with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Inogen

All Key Metrics — Inogen